Skip to main content
Log in

Letter to Editor: Inaccuracies in relating 25-hydroxyvitamin D to ischemic heart disease

  • Letter to the Editor
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Schmidt-Gayk H, Goossen J, Lendle F, Seidel D. Serum 25-hydroxycalciferol in myocardial infarction. Atherosclerosis 1977; 26: 55–58.

    Google Scholar 

  2. Bostick RM, Kushi LH, Wu Y, Meyer KA, Sellers TA, Folsom AR. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999; 149: 151–161.

    Google Scholar 

  3. Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: A community-based study. Int J Epidemiol 1990; 19: 559–563.

    Google Scholar 

  4. Rajasree S, Rajpal K, Kartha CC, et al. Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease. Eur J Epidemiol 2001; 17: 567–571.

    Google Scholar 

  5. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842–856.

    Google Scholar 

  6. Harinarayan CV, Gupta N, Kochupillai N. Vitamin D status in primary hyperparathyroidism in India. Clin Endocrinol (Oxf) 1995; 43: 351–358.

    Google Scholar 

  7. Goswami R, Gupta N, Goswami D, Marwaha RK, Tandon N, Kochupillai N. Prevalence and significance of low 25-hydroxyvitamin D concentrations in healthy subjects in Delhi. Am J Clin Nutr 2000; 72: 472–475.

    Google Scholar 

  8. Joshi SR. Hypovitaminosis D in patients attending a rheumatology clinic at a tertiary referral clinic. J Assoc Physician India 1999; 47: 463–464.

    Google Scholar 

  9. Chen C, Aerssens J, Holick M. Methods for the determination of circulating concentrations of 25-hydroxyvitamin D. J Nutr Biochem 1990; 1: 315–319.

    Google Scholar 

  10. Preece MA, Tomlinson S, Ribot CA, et al. Studies of vitamin D deficiency in man. Q J Med 1975; 44: 575–589.

    Google Scholar 

  11. Vieth R. Problems with direct 25-hydroxyvitamin D assays and the target amount of vitamin D nutrition desirable for patients with osteoporosis. Osteoporosis Int 2000; 11: 635–636.

    Google Scholar 

  12. Bouillon R, Van Herck E, Jans I, Tan BK, Van Baelen H, De Moor P. Two direct (nonchromatographic) assays for 25-hydroxyvitamin D. Clin Chem 1984; 30: 1731–1736.

    Google Scholar 

  13. Vieth R, Carter G. Difficulties with vitamin D nutrition research: Objective targets of adequacy, and assays for 25-hydroxyvitamin D. Eur J Clin Nutr 2001; 55: 221–222.

    Google Scholar 

  14. Moon J, Bandy B, Davison AJ. Hypothesis: Etiology of atherosclerosis and osteoporosis: Are imbalances in the calciferol endocrine system implicated? J Am Coll Nutr 1992; 11: 567–583.

    Google Scholar 

  15. Rao DS, Honasoge M, Divine GW, et al. Effect of vitamin D nutrition on parathyroid adenoma weight: Pathogenetic and clinical implications. J Clin Endocrinol Metab 2000; 85: 1054–1058.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vieth, R., Rao, D.S. Letter to Editor: Inaccuracies in relating 25-hydroxyvitamin D to ischemic heart disease. Eur J Epidemiol 18, 461–462 (2003). https://doi.org/10.1023/A:1024222208492

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024222208492

Keywords

Navigation